Your browser is no longer supported. Please, upgrade your browser.
Settings
LMNX [NASD]
Luminex Corporation
Index- P/E134.64 EPS (ttm)0.22 Insider Own0.20% Shs Outstand45.46M Perf Week6.11%
Market Cap1.41B Forward P/E28.30 EPS next Y1.06 Insider Trans-56.45% Shs Float44.24M Perf Month6.41%
Income10.40M PEG8.98 EPS next Q0.14 Inst Own92.10% Short Float6.85% Perf Quarter31.27%
Sales380.80M P/S3.70 EPS this Y-190.70% Inst Trans-4.81% Short Ratio5.05 Perf Half Y12.92%
Book/sh11.35 P/B2.63 EPS next Y16.94% ROA2.50% Target Price33.50 Perf Year13.39%
Cash/sh6.54 P/C4.57 EPS next 5Y15.00% ROE3.50% 52W Range20.61 - 41.69 Perf YTD29.28%
Dividend0.40 P/FCF- EPS past 5Y-17.60% ROI-2.80% 52W High-28.30% Beta0.55
Dividend %1.34% Quick Ratio5.00 Sales past 5Y8.10% Gross Margin57.80% 52W Low45.03% ATR1.88
Employees1247 Current Ratio6.40 Sales Q/Q34.80% Oper. Margin6.60% RSI (14)53.47 Volatility9.64% 6.37%
OptionableYes Debt/Eq0.39 EPS Q/Q131.70% Profit Margin4.50% Rel Volume1.07 Prev Close31.59
ShortableYes LT Debt/Eq0.39 EarningsFeb 08 AMC Payout95.50% Avg Volume600.07K Price29.89
Recom2.60 SMA202.17% SMA509.71% SMA2007.51% Volume643,179 Change-5.38%
Aug-18-20Resumed Piper Sandler Overweight $38
Sep-27-19Downgrade JP Morgan Neutral → Underweight $23 → $21
Jan-05-18Initiated BTIG Research Buy $24
Jan-18-17Initiated Deutsche Bank Sell $18
Oct-12-16Initiated Avondale Mkt Outperform $27
Aug-18-16Upgrade JP Morgan Underweight → Neutral
Aug-04-15Upgrade Wedbush Neutral → Outperform
Nov-05-13Reiterated UBS Neutral $24 → $21.50
Jul-30-13Downgrade UBS Buy → Neutral $22 → $24
Aug-23-12Upgrade UBS Neutral → Buy $25 → $22
Jul-31-12Downgrade William Blair Outperform → Mkt Perform
May-01-12Reiterated UBS Neutral $22 → $25
Mar-12-10Initiated Jefferies & Co Buy $20
Nov-18-09Initiated William Blair Mkt Perform
May-08-09Reiterated Wedbush Morgan Buy $26 → $28
Apr-14-09Initiated Piper Jaffray Neutral
Dec-12-08Downgrade Leerink Swann Outperform → Mkt Perform
Oct-16-08Initiated UBS Neutral
Oct-10-08Initiated Cowen & Co Neutral
Aug-08-08Reiterated Canaccord Adams Buy $24 → $26
Mar-02-21 09:44AM  
Feb-19-21 07:54AM  
06:30AM  
Feb-16-21 06:04AM  
Feb-14-21 01:32PM  
Feb-09-21 11:47PM  
09:59AM  
04:30AM  
Feb-08-21 05:35PM  
04:20PM  
04:01PM  
01:00PM  
Feb-05-21 10:11AM  
Feb-01-21 02:36AM  
Jan-27-21 07:00AM  
Jan-13-21 11:14AM  
Jan-12-21 06:00AM  
Dec-21-20 10:14AM  
Dec-16-20 11:39PM  
02:23PM  
Dec-10-20 01:57AM  
Dec-07-20 10:59AM  
Dec-05-20 11:32AM  
Nov-10-20 08:07AM  
Nov-05-20 11:32PM  
04:02PM  
Oct-29-20 12:35PM  
Oct-26-20 10:37AM  
Oct-22-20 07:00AM  
Oct-07-20 07:00AM  
Sep-28-20 08:02PM  
08:22AM  
Sep-24-20 04:05PM  
08:15AM  
04:58AM  
Sep-23-20 04:05PM  
Sep-18-20 06:02AM  
Sep-15-20 07:30AM  
Sep-03-20 11:31AM  
Aug-28-20 09:42AM  
Aug-27-20 12:39PM  
Aug-26-20 08:30AM  
Aug-05-20 09:08AM  
02:01AM  
Aug-04-20 06:25PM  
05:39PM  
04:36PM  
04:15PM  
04:01PM  
Jul-28-20 12:33PM  
Jul-22-20 05:00AM  
Jul-21-20 08:13AM  
Jul-20-20 01:16PM  
07:17AM  
05:00AM  
Jul-17-20 11:40AM  
Jul-16-20 10:06AM  
Jul-13-20 10:07AM  
Jul-08-20 09:46AM  
07:00AM  
Jul-06-20 09:28AM  
Jul-01-20 05:00AM  
Jun-30-20 09:37AM  
Jun-29-20 04:01PM  
Jun-28-20 05:23PM  
Jun-03-20 11:30AM  
May-28-20 04:52PM  
10:33AM  
May-26-20 10:34AM  
May-22-20 07:00AM  
May-20-20 08:44AM  
May-12-20 08:06PM  
12:56PM  
May-11-20 08:44AM  
May-08-20 03:55PM  
07:00AM  
May-07-20 08:54AM  
May-05-20 09:41AM  
May-04-20 09:31PM  
Apr-30-20 09:33AM  
Apr-22-20 08:30AM  
Apr-17-20 09:12AM  
Apr-14-20 07:58AM  
Apr-07-20 08:23AM  
Apr-06-20 04:30PM  
07:30AM  
Mar-31-20 07:30AM  
Mar-30-20 11:13AM  
Mar-27-20 04:05PM  
07:45AM  
Mar-17-20 09:02AM  
Mar-13-20 07:30AM  
Mar-11-20 11:30AM  
Mar-04-20 09:33AM  
07:30AM  
Mar-02-20 08:27AM  
Mar-01-20 09:00PM  
Feb-24-20 09:00AM  
Feb-18-20 11:57AM  
Feb-17-20 05:31AM  
Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; ARIES system, a sample to answer real-time PCR platform; ARIES M1 system, a single-module version of the ARIES System; VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market; FlowSight Imaging Flow cytometer; ImageStream System; CellStream Flow Cytometer; Guava easyCyte line; and Muse Cell Analyzer. The company also provides MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; SYNCT data management software solutions; TDAS, an analysis program designed for development and optimization of nucleic acid assays; IDEAS, an image analysis software; and xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism. In addition, it offers MultiCode assays and products comprising HSV 1&2 assays, and other products to detect infectious agents in clinical samples; ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 assays, ARIES FLU A/B and RSV assays, ARIES group A strep assays, ARIES bordetella assays, ARIES GBS assay, and ARIES C. difficile assays; and VERIGENE test cartridges. The company serves pharmaceutical companies, clinical laboratories, and research and medical institutions. Luminex Corporation was founded in 1995 and is based in Austin, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CURRIE HARRISS TSVP, Finance & CFOMar 01Option Exercise18.265,32597,235231,142Mar 01 04:31 PM
CURRIE HARRISS TSVP, Finance & CFOMar 01Sale32.355,325172,262226,868Mar 01 04:31 PM
Bennett Todd C.SVP, Global Sales & Cust OpsFeb 25Option Exercise19.09121,5072,319,018155,640Mar 01 04:33 PM
Bennett Todd C.SVP, Global Sales & Cust OpsFeb 25Sale34.06121,5074,138,08834,197Mar 01 04:33 PM
Eck Stephen L.DirectorNov 25Buy22.404,487100,50137,807Nov 30 11:26 AM
Rew Richard W. IISVP, Gen Counsel & Corp SecyAug 05Option Exercise15.9311,176178,03444,329Aug 05 06:55 PM
SHAMIR NACHUMPresident & CEOAug 05Option Exercise15.938,559136,345197,583Aug 05 06:56 PM
Shapiro EricSR VP, GLOBAL MARKETINGAug 05Option Exercise16.7414,179237,35648,046Aug 06 09:24 AM
Shapiro EricSR VP, GLOBAL MARKETINGAug 05Sale40.1614,179569,42933,867Aug 06 09:24 AM
Fairchild NancySVP, Human ResourcesAug 05Sale40.1624,283975,20533,828Aug 06 09:22 AM
SHAMIR NACHUMPresident & CEOAug 05Sale40.168,559343,729189,632Aug 05 06:56 PM
Rew Richard W. IISVP, Gen Counsel & Corp SecyAug 05Sale40.9311,176457,43433,153Aug 05 06:55 PM
Rew Richard W. IISVP, Gen Counsel & Corp SecyAug 04Option Exercise15.933,78660,31136,939Aug 05 06:55 PM
SHAMIR NACHUMPresident & CEOAug 04Option Exercise15.93116,4411,854,905305,465Aug 05 06:56 PM
LOEWENBAUM G WALTER IIDirectorAug 04Sale39.0250,0001,951,030450,441Aug 06 01:08 PM
SHAMIR NACHUMPresident & CEOAug 04Sale39.50116,4414,599,420189,024Aug 05 06:56 PM
Rew Richard W. IISVP, Gen Counsel & Corp SecyAug 04Sale38.933,786147,38933,153Aug 05 06:55 PM
Rew Richard W. IISVP, Gen Counsel & Corp SecyAug 03Option Exercise15.937,389117,70740,542Aug 05 06:55 PM
SHAMIR NACHUMPresident & CEOAug 03Option Exercise15.93125,0001,991,250314,024Aug 05 06:56 PM
SHAMIR NACHUMPresident & CEOAug 03Sale38.51125,0004,813,138189,024Aug 05 06:56 PM
Rew Richard W. IISVP, Gen Counsel & Corp SecyAug 03Sale38.937,389287,65433,153Aug 05 06:55 PM
Fairchild NancySVP, Human ResourcesJul 21Option Exercise18.5469,2821,284,29995,786Jul 21 06:48 PM
Fairchild NancySVP, Human ResourcesJul 21Sale37.8569,2822,622,32458,111Jul 21 06:48 PM
Rew Richard W. IISVP, Gen Counsel & Corp SecyJul 17Option Exercise15.9311,175178,01843,984Jul 17 09:02 PM
Myers RandallSVP, Global Mfg and QualityJul 17Option Exercise20.0241,200824,77352,359Jul 20 08:14 PM
Fairchild NancySVP, Human ResourcesJul 17Option Exercise19.135095758,161Jul 20 08:13 PM
Collins Charles J.SR VP, R&D - USJul 17Option Exercise18.6422,748423,91747,897Jul 20 08:13 PM
Collins Charles J.SR VP, R&D - USJul 17Sale37.0022,748841,67634,554Jul 20 08:13 PM
Fairchild NancySVP, Human ResourcesJul 17Sale37.85501,89358,111Jul 20 08:13 PM
Myers RandallSVP, Global Mfg and QualityJul 17Sale37.5041,2001,545,00033,588Jul 20 08:14 PM
Rew Richard W. IISVP, Gen Counsel & Corp SecyJul 17Sale36.9311,175412,69333,153Jul 17 09:02 PM
Fairchild NancySVP, Human ResourcesJul 15Option Exercise17.1156,525967,14590,264Jul 17 10:52 AM
Collins Charles J.SR VP, R&D - USJul 15Option Exercise15.9337,252593,42471,462Jul 17 10:52 AM
LOEWENBAUM G WALTER IIDirectorJul 15Sale34.9650,0001,748,010709,415Jul 17 10:52 AM
LOEWENBAUM G WALTER IIDirectorJul 15Sale35.9050,0001,794,915500,441Jul 17 10:52 AM
Collins Charles J.SR VP, R&D - USJul 15Sale34.5037,2521,285,29834,554Jul 17 10:52 AM
Fairchild NancySVP, Human ResourcesJul 15Sale36.0156,5252,035,24058,111Jul 17 10:52 AM
Fairchild NancySVP, Human ResourcesJul 06Option Exercise16.4223,475385,49477,424Jul 07 10:46 AM
Fairchild NancySVP, Human ResourcesJul 06Sale33.0023,475774,67557,424Jul 07 10:46 AM
LOEWENBAUM G WALTER IIDirectorJul 06Sale33.0026,347869,382759,415Jul 07 05:38 PM
LOEWENBAUM G WALTER IIDirectorJul 02Sale32.8615,800519,152785,762Jul 06 08:17 AM
LOEWENBAUM G WALTER IIDirectorJul 01Sale32.887,853258,244801,562Jul 06 08:17 AM
LOEWENBAUM G WALTER IIDirectorJun 05Sale30.6944,4951,365,600809,415Jun 05 10:59 AM
LOEWENBAUM G WALTER IIDirectorJun 04Sale31.0255,5051,721,798853,910Jun 05 10:59 AM
Myers RandallSVP, Global Mfg and QualityMay 26Option Exercise18.1175,0001,358,16277,543May 27 09:53 AM
Myers RandallSVP, Global Mfg and QualityMay 26Sale31.0575,0002,328,60033,588May 27 09:53 AM
LOEWENBAUM G WALTER IIDirectorMay 22Sale31.2786,6572,709,756543,460May 26 11:51 AM
SHAMIR NACHUMPresident & CEOApr 16Option Exercise21.10125,0002,637,500314,024Apr 16 11:26 AM
SHAMIR NACHUMPresident & CEOApr 16Sale31.00125,0003,875,000189,024Apr 16 11:26 AM
SHAMIR NACHUMPresident & CEOApr 15Option Exercise21.1079,0921,668,841268,116Apr 16 11:26 AM
SHAMIR NACHUMPresident & CEOApr 15Sale30.0079,0922,372,760189,024Apr 16 11:26 AM
SHAMIR NACHUMPresident & CEOApr 14Option Exercise21.1045,908968,659234,932Apr 16 11:26 AM
SHAMIR NACHUMPresident & CEOApr 14Sale30.0045,9081,377,240189,024Apr 16 11:26 AM
CURRIE HARRISS TSVP, Finance & CFOMar 09Option Exercise16.5511,217185,641222,913Mar 10 05:09 PM